Connor, Clark & Lunn Investment Management Ltd. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$2,228,000
+4.0%
202,525
-13.0%
0.02%
-5.6%
Q4 2015$2,143,000
+48.7%
232,900
+12.1%
0.02%
+50.0%
Q3 2015$1,441,000
-40.5%
207,675
-15.7%
0.01%
-45.5%
Q2 2015$2,420,000
+12.3%
246,400
+1.4%
0.02%
+22.2%
Q1 2015$2,154,000
-7.7%
243,100
-8.7%
0.02%
-5.3%
Q4 2014$2,334,000
+36.7%
266,400
+7.5%
0.02%
+35.7%
Q3 2014$1,707,000
+65.6%
247,700
+34.5%
0.01%
+100.0%
Q2 2014$1,031,000
+17.7%
184,100
+5.6%
0.01%
+16.7%
Q1 2014$876,000174,4000.01%
Other shareholders

There were no reported owners of SCICLONE PHARMACEUTICALS INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of SCICLONE PHARMACEUTICALS INC shareholders